CD34 and diabetes mellitus: To the best of our knowledge, the present study for the first time indicated that CD34 is specifically localized on rat islet α-cells and higher CD34 expression can predict reduced β-cell number in pancreatic islets, which may be utilized as a biomarker of islet β-cell in the early diagnosis of diabetes.